CRISPR/Cas9-mediated GLA gene editing in human iPSC-derived ventricular cardiomyocytes as a model of Fabry cardiomyopathy
The generation of this novel in vitro model of human left ventricular–specific cardiomyocytes harboring GLA mutations provides a rapid disease-relevant platform for studying Fabry cardiomyopathy and broadens opportunities for drug screening and investigation of disease-related molecular mechanisms.